Tokyo stocks extended their decline on the morning of Sept. 29, with the Nikkei Stock Average falling more than 800 points at one stage in a broad-based sell-off. Trading later showed selective buying in shares that had announced upward earnings revisions or dividend increases the previous day, while stocks going ex-rights for dividends and those affected by disappointing clinical trial results faced heavy selling.